Alogliptin and metformin

DRUG4 trials

Sponsors

Takeda, Fourth People's Hospital of Shenyang

Conditions

Diabetes MellitusDiabetes Mellitus, Type 2Type 2 Diabetes Mellitus

Phase 2

Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in Japan

CompletedNCT01318109

TakedaType 2 Diabetes Mellitus

Start: 2008-08-31End: 2009-04-30Updated: 2012-02-03

Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in Japan

CompletedNCT01318135

TakedaType 2 Diabetes Mellitus

Start: 2009-01-31End: 2010-04-30Updated: 2012-08-16

Phase 3

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

CompletedNCT00286442

TakedaDiabetes Mellitus

Start: 2006-03-31End: 2007-06-30Updated: 2012-02-03

Unknown Phase

The Effect of Alogliptin on Pulmonary Function in Obese Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy

CompletedNCT02798172

Fourth People's Hospital of ShenyangDiabetes Mellitus, Type 2

Start: 2014-05-31End: 2015-08-31Updated: 2016-06-14

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01

Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study.

2012-07-1224 citations